EUVIMEDEUVIMED entdecken
Open Access

A structure-guided approach to predict MHC-I restriction of T cell receptors for public antigens

Sagar Gupta, Nikolaos G Sgourakis

Structure · 2025

DOI: 10.1016/j.str.2025.06.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2025. Verfasst von Sagar Gupta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Biochemistry and Biophysi…. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptides presented by major histocompatibility complex class I (MHC-I) proteins provide biomarkers for therapeutic targeting using T cell receptors (TCRs), TCR-mimicking antibodies (TMAs), or other engineered protein binders. Despite the extreme sequence diversity of the human leukocyte antigen (HLA, the human MHC), a given TCR or TMA is restricted to recognize epitopic peptides in the context of a limited set of different HLA alleles. Here, guided by our analysis of 98 TCR:pHLA complex structures, we identify TCR contact residues and classify 148 common HLA alleles into T cell cross-reactivity groups (T-CREGs) on the basis of their presented surface features. Insights from our work have actionable value for predicting MHC-I restriction of TCRs, guiding therapeutic expansion of existing TCR-based approaches and informing the selection of peptide targets for the development of new therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-CellHistocompatibility Antigens Class IHumansProtein BindingModels, MolecularPeptidesCross ReactionsAllelesBinding Sites

Stichwörter der Autor:innen

T cell receptoralloreactivityhuman leucocyte antigenprotein interfacereceptor cross-reactivity

Substanzen

Receptors, Antigen, T-CellHistocompatibility Antigens Class IPeptides

Autor:innen und Institutionen

  • Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Phi…
  • Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medi…

Förderung

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases Division of Intramural Research
  • National Cancer Institute Division of Cancer Epidemiology and Genetics
  • Cancer Research UK
  • NIH National Institute of General Medical Sciences

Zitieren

APA

Gupta, S., & Sgourakis, N. G. (2025). A structure-guided approach to predict MHC-I restriction of T cell receptors for public antigens. Structure. https://doi.org/10.1016/j.str.2025.06.011

Vancouver

Gupta S, Sgourakis NG. A structure-guided approach to predict MHC-I restriction of T cell receptors for public antigens. Structure. 2025. doi:10.1016/j.str.2025.06.011

BibTeX
@article{Gupta2025,
  author = {Gupta, Sagar and Sgourakis, Nikolaos G},
  title = {A structure-guided approach to predict MHC-I restriction of T cell receptors for public antigens},
  journal = {Structure},
  year = {2025},
  doi = {10.1016/j.str.2025.06.011}
}
Kostenlos starten →